Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 50 citing articles:

Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
Duaa Fahs, Dima Salloum, Mona Nasrallah, et al.
Diagnostics (2023) Vol. 13, Iss. 9, pp. 1559-1559
Open Access | Times Cited: 27
The role of the thyroid in polycystic ovary syndrome
Huanhuan Fan, Qingling Ren, Zhejin Sheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 20
Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome
Qian Yu, Yun Tong, Yaqiong Zeng, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Polycystic ovary syndrome and adipose tissue
Madleen Lemaître, Sophie Christin‐Maître, V. Kerlan
Annales d Endocrinologie (2023) Vol. 84, Iss. 2, pp. 308-315
Open Access | Times Cited: 16
Lipid accumulation product is an effective predictor of metabolic syndrome in non-obese women with polycystic ovary syndrome
Wenju Han, Meiwei Zhang, Haiyan Wang, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 5
Correlation between chronic low-grade inflammation and glucose and lipid metabolism indicators in polycystic ovary syndrome
Yan Zhou, Xia Wang, Siqi Guo, et al.
Gynecological Endocrinology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 5
The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date
Tea Shehu Kolnikaj, Rok Herman, Andrej Janež, et al.
Medicina (2024) Vol. 60, Iss. 2, pp. 244-244
Open Access | Times Cited: 4
Metabolic Dysfunction-Associated Steatotic Liver Disease and Polycystic Ovary Syndrome: A Complex Interplay
Konstantinos Arvanitakis, Elena Chatzikalil, Georgios Kalopitas, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4243-4243
Open Access | Times Cited: 4
Per- and polyfluoroalkyl substances exposure is associated with polycystic ovary syndrome risk among women attending a fertility clinic
Yu Zhang, Leah J. Martin, Vicente Mustieles, et al.
The Science of The Total Environment (2024) Vol. 950, pp. 175313-175313
Closed Access | Times Cited: 4
Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome
Emre Uysal, Ömer Tammo, ESRA SÖYLEMEZ, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
SUPPRESSION OF ADIPOSE TGF-β1 BY PROBIOTICS ALLEVIATES METABOLIC DISTURBANCE IN EXPERIMENTALLY INDUCED PCOS
Kehinde S. Olaniyi, Doris O Okara, Stephanie E. Areloegbe
Prostaglandins & Other Lipid Mediators (2025) Vol. 178, pp. 106989-106989
Closed Access
Triglyceride–glucose index and lipid ratios in women with and without polycystic ovary syndrome: a systematic review and meta-analysis
Juan R. Ulloque‐Badaracco, Esteban A. Alarcón‐Braga, Enrique A. Hernández-Bustamante, et al.
Therapeutic Advances in Endocrinology and Metabolism (2025) Vol. 16
Open Access
Gut Microbiome Composition in Polycystic Ovary Syndrome Adult Women: A Systematic Review and Meta-analysis of Observational Studies
Qiaoying Zhu, N Zhang
Reproductive Sciences (2024) Vol. 31, Iss. 7, pp. 1800-1818
Closed Access | Times Cited: 3
Lipoprotein alterations in endocrine disorders - a review of the recent developments in the field
Michał Olejarz, Ewelina Szczepanek‐Parulska, Marek Ruchała
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Assessing the clinical diagnostic value of anti-Müllerian hormone in polycystic ovarian syndrome and its correlation with clinical and metabolism indicators
Li Wang, Mengjun Luo, Xiaoyu Yu, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Exploring heart rate variability in polycystic ovary syndrome: implications for cardiovascular health: a systematic review and meta-analysis
Seyedeh-Tarlan Mirzohreh, Padideh Panahi, Fariba Heidari
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome
Cuiyu Tan, Shuqiang Huang, Liying Xu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions
Haoyu Peng, Junyi Ren, Yang Zhao, et al.
Diabetes Research and Clinical Practice (2025), pp. 112235-112235
Closed Access
FSH, LH, Lipid and Adipokines in Polycystic Ovary Syndrome: Clinical Biochemistry Insights for Diagnosis and Management
Wafa M. Merza, Abeer Khalid Yaseen, Maha Adel Mahmood
The Journal of Steroid Biochemistry and Molecular Biology (2025) Vol. 251, pp. 106773-106773
Closed Access
Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
Marzena Jabczyk, Justyna Nowak, Paweł Jagielski, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 302-302
Open Access | Times Cited: 9
HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study
Alexandra E. Butler, Abu Saleh Md Moin, Željko Reiner, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 855-855
Open Access | Times Cited: 9
Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome
Tianrui Jing, Yifan Wu, Anran Wan, et al.
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1101-1101
Open Access | Times Cited: 8
The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome
Ting Zhao, Tao Xinghua, Xiao Xiao, et al.
Gynecological Endocrinology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 2
Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
Taïeb Ach, Amri Feryel
Diagnostics (2024) Vol. 14, Iss. 22, pp. 2578-2578
Open Access | Times Cited: 2
Significance of LHCGR polymorphisms in polycystic ovary syndrome: an association study
Sukhjashanpreet Singh, Mandeep Kaur, Archana Beri, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top